Related Experiment Videos
[Mutation analysis of transforming growth factor-beta type II receptor gene in human gastric cancer tissues]
Y Ke1, K Hagiwara, X Su
1Beijing Institute for Cancer Research.
Objective:
Mutations which cause abarrent expression of transforming type II receptor (TGF-beta RII) are responsible for the escape of some tumor cells from growth control midiated by TGF-beta. Two mutation hot spots (cDNA 709-718, 1931-1936) have been reported on human colon cancer cell lines. To elucidate the situation of this gene in human gastric cancer, 44 gastric cancer tissues were examined for mutation at the two hot spots.
Methods:
Genomic DNA extracted from the cancer tissues was PCR amplified and analysed by silver stain for single stranded conformation polymorphism. Positive samples were sequenced by dry-primer automatic sequencing method.
Results:
The data revealed a deletion rate of 6.8% (3/44) of the 1st hot spot; CA insertion of the 2nd hot spot was not found in all 44 gastric cancer tissues.
Conclusion:
The mutation incidence of TGF-beta R II in human gastric cancer is low.
Insights
Mutations in the transforming growth factor beta type II receptor (TGF-beta RII) gene are uncommon in human gastric cancer. This study found a low mutation incidence, suggesting TGF-beta RII mutations are not a primary driver of gastric tumor development.
Area of Science:
- Molecular biology
- Cancer genetics
- Oncology
Context:
- Transforming growth factor beta (TGF-beta) is a crucial regulator of cell growth and differentiation.
- Aberrant TGF-beta signaling, often due to mutations in its receptors, contributes to tumor progression in various cancers.
- The transforming growth factor beta type II receptor (TGF-beta RII) is a key component of the TGF-beta signaling pathway.
Purpose:
- To investigate the mutation status of the TGF-beta RII gene in human gastric cancer.
- To determine the frequency of mutations at two previously identified hot spots in the TGF-beta RII gene.
- To assess the role of TGF-beta RII mutations in gastric cancer development.
Summary:
- A study examined 44 human gastric cancer tissues for mutations in two hot spots of the TGF-beta RII gene.
- Analysis revealed a 6.8% deletion rate at the first hot spot (cDNA 709-718).
- No CA insertions were detected at the second hot spot (cDNA 1931-1936), indicating a low overall mutation incidence.
Impact:
- The findings suggest that mutations in the TGF-beta RII gene are infrequent in human gastric cancer.
- This low incidence implies that TGF-beta RII mutations may not be a major factor in the pathogenesis of most gastric cancers.
- Further research may explore other genetic alterations contributing to TGF-beta pathway dysregulation in gastric tumorigenesis.